NCT06297174View on ClinicalTrials.gov

Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

September 17, 2024

Study Completion Date

September 20, 2024

Conditions
Healthy Vollunteer
Interventions
DRUG

Racecadotril 100 mg Capsules

Racecadotril 100 mg Capsules (test drug)

DRUG

HIDRASEC®

HIDRASEC® (reference drug)

Sponsors

Lead Sponsor

Pharma Nueva
All Listed Sponsors
lead

Pharma Nueva

INDUSTRY

NCT06297174 - Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter